客户发表文献

论文在线提交

至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

开始时间
页码: 127/199 每页显示数量
miR-153-3p Suppresses Inhibitor of Growth Protein 2 Expression to Function as Tumor Suppressor in Acute Lymphoblastic Leukemia.
Authors: JiangJian,LiuYan,ZhaoYanxia,TianFei,WangGa
Journal: Technol. Cancer Res. Treat.
PubMed ID: 31138034
Doi: 10.1177/1533033819852990
Products & Services: Custom Vector Construction   
Raloxifene nano-micelles effect on triple-negative breast cancer is mediated through estrogen receptor-β and epidermal growth factor receptor.
Authors: GreishKhaled,NehoffHayley,BahmanFatemah,PritchardTara,TaurinSebas
Journal: J Drug Target
PubMed ID: 30615483
Doi: 10.1080/1061186X.2019.1566341
Products & Services: Custom Vector Construction   
Generation and characterization of novel anti-DR4 and anti-DR5 antibodies developed by genetic immunization.
Authors: DubuissonAgathe,FavreauCécile,FourmauxEric,LareureSabrina,Rodrigues-SaraivaRafael,Pellat-DeceunynckCatherine,El AlaouiSaid,MicheauOli
Journal: Cell Death Dis
PubMed ID: 30718507
Doi: 10.1038/s41419-019-1343-5
Products & Services: Custom Vector Construction   
miR-185-5p targets ROCK2 and inhibits cell migration and invasion of hepatocellular carcinoma.
Authors: NiuYuexiang,TangGo
Journal: Oncol Lett
PubMed ID: 31105794
Doi: 10.3892/ol.2019.10144
Products & Services: Custom Vector Construction   
The FOXC2 Transcription Factor Promotes Melanoma Outgrowth and Regulates Expression of Genes Associated With Drug Resistance and Interferon Responsiveness.
Authors: Hargadon KM, Györffy B,, Strong EW, Tarnai BD, Thompson JC, Bushhouse DZ, Johnson CE, Williams CJ.
Journal: Cancer Genomics Proteomics
PubMed ID: 31659103
Doi: 10.21873/cgp.20152
Products & Services: Custom Vector Construction   
CAR T-Cells Targeting the Integrin αvβ6 and Co-Expressing the Chemokine Receptor CXCR2 Demonstrate Enhanced Homing and Efficacy against Several Solid Malignancies.
Authors: Whilding LM, Halim L, Draper B, Parente-Pereira AC, Zabinski T, Davies DM, Maher J,,.
Journal: Cancers (Basel)
PubMed ID: 31091832
Doi: 10.3390/cancers11050674
Products & Services: Custom Vector Construction   
CR6-interacting factor 1 controls autoimmune arthritis by regulation of signal transducer and activator of transcription 3 pathway and T helper type 17 cells.
Authors: Park JS, Choi SY, Hwang SH, Kim SM, Choi J, Jung KA, Kwon JY, Kong YY, Cho ML,,, Park SH,.
Journal: Immunology
PubMed ID: 30585643
Doi: 10.1111/imm.13042
Products & Services: Custom Vector Construction   
Development of a multiple-antigen protein fusion vaccine candidate that confers protection against Bacillus anthracis and Yersinia pestis
Authors: Gallagher TB1, Mellado-Sanchez G1, Jorgensen AL1, Moore S2, Nataro JP3, Pasetti MF1, Baillie LW4.
Journal: PLoS Negl Trop Dis.
PubMed ID: 31430284
Doi: 10.1371/journal.pntd.0007644
Products & Services: Custom Vector Construction   
Genetically encoded fluorescent indicators for imaging intracellular potassium ion concentration.
Authors: Shen Y,, Wu SY, Rancic V, Aggarwal A, Qian Y, Miyashita SI, Ballanyi K, Campbell RE,, Dong M.
Journal: Commun Biol
PubMed ID: 30652129
Doi: 10.1038/s42003-018-0269-2
Products & Services: Custom Vector Construction   
Corrigendum to "Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models".
Authors: ZhangQing,ZhangHaixu,DingJiage,LiuHongyan,LiHuizhong,LiHailong,LuMengmeng,MiaoYangna,LiLiantao,ZhengJun
Journal: J Immunol Res
PubMed ID: 31032372
Doi: 10.1155/2019/2070562
Products & Services: Custom Vector Construction   
1
...
126 127 128
...
199